Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| DA40316-08S2 | Other Grant/Funding Number | National Institute on Drug Abuse |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Institute on Drug Abuse (NIDA) | NIH |
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to find out whether a Facebook group will help Native women in recovery from opioid use.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Wiidookaage'win Facebook Group | Experimental | The Wiidookaage'win Facebook Group is an online, asynchronous group intervention that will run for 3-months with approximately 30 days of content developed. It is private and hidden, meaning only those in the study will be able to see or find the group. It will be moderated by two women from the study team (one AIAN and one biracial). A back-up moderator will also have access to the group. Participants will be able to comment, react, view, and post in the intervention group, and are encouraged to interact with one another. |
|
| Online Resources Landing Page | No Intervention | The Online Resources Landing Page was developed by the study team using https://carrd.co. It includes links to local programs in family services, substance use recovery, legal advocacy, etc. which already exist and may help support their recovery. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Wiidookaage'win Facebook Group | Behavioral | An online social media group program that incorporates social support, mindfulness-based, and cultural practices that may support OUD recovery. |
| Measure | Description | Time Frame |
|---|---|---|
| Feasibility of Facebook Intervention | The study team will measure the feasibility from the combined reports of recruitment, study retention, level of Facebook intervention uptake/engagement, and treatment satisfaction. | 3 months |
| Measure | Description | Time Frame |
|---|---|---|
| Timeline Follow-back Interview and UDS to measure Opioid Abstinence | The study team will explore the preliminary differential impact of the intervention compared with the control condition on opioid abstinence and MOUD continuation. Opioid and other substance use will be assessed through monthly Timeline Follow-Back (TLFB) interviews (Sobell & Sobell, 1992; Wray et al., 2016). At 1, 3, and 6-months, the study team will obtain a UDS that will be used along with the TLFB interviews to measure opioid abstinence. |
| Measure | Description | Time Frame |
|---|---|---|
| Perceived Stress Scale and Communal Mastery Scale | The study team will explore the differential impact of the intervention compared with the control condition on constructs targeted by our intervention, specifically perceived stress and coping with stressful life circumstances from a more collectivist orientation, respectively. | 3 months |
Inclusion Criteria:
Exclusion Criteria:
Participants may be cisgender or transgender women. They may also identify as Two Spirit and include "woman" as part of their gender identity.
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Ashley Brown | Contact | 1-833-880-2600 | wiidookaagewin@mayo.edu |
| Name | Affiliation | Role |
|---|---|---|
| Christi A Patten, PhD | Mayo Clinic | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Mayo Clinic | Recruiting | Rochester | Minnesota | 55901 | United States |
Not provided
| Label | URL |
|---|---|
| Mayo Clinic Clinical Trials | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| ICF | No | No | Yes | Informed Consent Form | Jul 12, 2024 | May 1, 2026 | ICF_000.pdf |
Not provided
| ID | Term |
|---|---|
| D009293 | Opioid-Related Disorders |
| ID | Term |
|---|---|
| D000079524 | Narcotic-Related Disorders |
| D019966 | Substance-Related Disorders |
| D064419 | Chemically-Induced Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 6 months |
| Reporting MOUD continuation | The study team will summarize MOUD continuation as the proportion of participants reporting current use at 6-month follow-up. | 6 months |